EMA Panel Backs Belimumab for Children With Lupus

Share this post

An EMA panel recommended extending the indication for belimumab to children aged 5 years and older with systemic lupus erythematosus.
International Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply